Advanced search
Publication Cover
Pediatric Hematology and Oncology Volume 29, 2012 - Issue 8
Submit an article Journal homepage
215
Views
2
CrossRef citations to date
0
Altmetric
LEUKEMIA/LYMPHOMA

High-Risk ALK Negative Anaplastic Large-Cell Lymphoma Presenting with Hypereosinophilic Syndrome in a 2.5-Year-Old Child

Funda TekkeşinDepartment of Pediatric Oncology, Faculty of Medicine, Gazi University, Ankara, TurkeyCorrespondence[email protected]
,
Faruk Güçlü PınarlıDepartment of Pediatric Oncology, Faculty of Medicine, Gazi University, Ankara, Turkey
,
Zühre KayaDepartment of Pediatric Hematology, Faculty of Medicine, Gazi University, Ankara, Turkey
,
Aynur OğuzDepartment of Pediatric Oncology, Faculty of Medicine, Gazi University, Ankara, Turkey
,
Ceyda KaradenizDepartment of Pediatric Oncology, Faculty of Medicine, Gazi University, Ankara, Turkey
,
Arzu OkurDepartment of Pediatric Oncology, Faculty of Medicine, Gazi University, Ankara, Turkey
&
Nalan AkyürekDepartment of Pathology, Faculty of Medicine, Gazi University, Ankara, Turkey
 show all
Pages 686-690 | Received 31 Jul 2012, Accepted 26 Aug 2012, Published online: 26 Sep 2012

REFERENCES

  • Chusid MJ, Dak DC, West BC, Wolff SM. The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine. 1975;54:1–27.
  • Gleich GJ, Leiferman KM. The hypereosinophilic syndromes: current concepts and treatments. Brit J Haematol. 2009;145:271–285.
  • van Grotel M, de Hoog M, de Krijger RR, Hypereosinophilic syndrome in children. Leuk Res. 2012;36:1249–1254.
  • Helbig G, Kyrcz-Krzemien S. Diagnostic and therapeutic management in patients with hypereosinophilic syndromes. Pol Arch Med Wewn. 2011;121:44–51.
  • Bank I, Amariglio N, Reshef A, The hypereosinophilic syndrome associated with CD4+CD3 helper type 2 (Th2) lymphocytes. Leuk Lymphoma. 2001;42:123–133.
  • Rothenberg ME, Hogan SP. The eosinophil. Annu Rev Immunol. 2006;24:147–174.
  • Lanzkowsky P. Manual of Hematology and Oncology. 5th ed. Burlington, MA: Elsevier; 2011:297–302.
  • Mckelvie PA, Oon S, Romas E, A case of systemic anaplastic lymphoma kinase–negative anaplastic large cell lymphoma associated with hypereosinophilia, granulomatous myositis and vasculitis. Leuk Lymphoma. (in press). Epub ahead of print: May 21, 2012 http://informahealthcare.com/doi/ abs/10.3109/10428194.2012.677592.
  • Ju E, Adigun C, Dunphy C, Anaplastic large cell lymphoma: an unusual presentation in a 7 year old girl. Pediatr Dermatol. 2012;29:498–503.
  • Jaffe ES. Anaplastic large cell lymphoma: the shifting sands of diagnostic hematopathology. Mod Pathol. 2001;14:219–228.
  • ten Berge RL, Oudejans JJ, Ossenkoppele GJ, Meijer CJ. ALK- negative systemic anaplastic large cell lymphoma: differential diagnostic and prognostic aspects—a review. J Pathol. 2003;200:4–15.
  • Kumar S, Pittaluga S, Raffeld M, Primary cutaneous CD-30 positive anaplastic large cell lymphoma in childhood: report of 4 cases and review of the literature. Pediatr Dev Pathol. 2005;8:52–60.
  • Le Deley MJ, Reiter A, Williams D, European intergroup for childhood non-hodgkin lymphoma. Prognostic factors in childhood anaplastic large cell lymphoma: results of a large European intergroup study. Blood. 2008;111:1560–1566.
  • Pileri SA, Agostinelli C, Bacci F, Pathobiology of ALK-negative anaplastic large cell lymphoma. Pediatr Rep. 2011;3:e5.
  • Mussolin L, Pillon M, d'Amore ES, Prevalence and clinical implications of bone marrow involvement in pediatric anaplastic large cell lymphoma. Leukemia. 2005;19:1643–1647.
  • Damm-Welk C, Busch K, Burkhardt B, Prognostic significance of circulating tumor cells in bone marrow or peripheral blood as detected by qualitative and quantitative PCR in pediatric NPM-ALK-positive anaplastic large-cell lymphoma. Blood. 2007;110:670–677
  • Vecsei A, Attarbaschi A, Krammer U, Pruritus in pediatric non-Hodgkin lymphoma. Leuk Lymphoma. 2002;43:1885–1887.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.